DANIELA HARIRCHI: Open Payments
NPI 1285230763 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 49 payments from 13 companies in 2025. Trend: 2023 $630 · 2024 $1,168 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $269 |
| Amgen Inc. | 12 | $151 |
| Merck Sharp & Dohme LLC | 6 | $117 |
| Alnylam Pharmaceuticals Inc. | 3 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| PFIZER INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| AtriCure, Inc. | 1 | $33 |
| Esperion Therapeutics, Inc. | 1 | $29 |
Products named: LEQVIO, Repatha, VERQUVO, ENTRESTO, AMVUTTRA, LifeVest, Kerendia, ELIQUIS.
Industry payments across FL — which companies pay providers there.
